{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Genetically modified organisms at the crossroads: Comments on\" Genetically modified crops: risks and promise\" by Gordon Conway", "pub_year": 2000, "citation": "Conservation Ecology 4 (1), 2000", "author": "Brian Walker and Mark Lonsdale", "journal": "Conservation Ecology", "volume": "4", "number": "1", "publisher": "Resilience Alliance", "abstract": "Life-sciences firms such as Novartis, AstraZeneca, and Monsanto are at a crossroads. Their agribusiness divisions have been hit by a double whammy: already suffering from a slump in commodity prices (eg, prices for wheat and soybeans have fallen 30% over the last two years), they have now been badly hit by a consumer backlash against genetically modified crops. Although this backlash is most vehement in Europe, it is intensifying in the United States.It has been argued that the industry made a major strategic mistake in leading the genetically modified organism (GMO) charge with organisms intended primarily to increase the profitability of farming systems rather than those that might, say, improve human health or help solve environmental problems such as waste-site contamination or agricultural soil degradation. Taking the profitability approach has led to public disquiet, because it is perceived that the \u2026"}, "filled": true, "author_pub_id": "1SGgB20AAAAJ:kF1pexMAQbMC", "num_citations": 18, "citedby_url": "/scholar?hl=en&cites=12841010275285712928", "cites_id": ["12841010275285712928"], "pub_url": "https://www.jstor.org/stable/26271744", "url_related_articles": "/scholar?oi=bibs&hl=en&q=related:IMCLj89uNLIJ:scholar.google.com/", "cites_per_year": {"2000": 3, "2001": 0, "2002": 1, "2003": 3, "2004": 0, "2005": 0, "2006": 1, "2007": 2, "2008": 0, "2009": 1, "2010": 0, "2011": 0, "2012": 1, "2013": 0, "2014": 0, "2015": 0, "2016": 2, "2017": 0, "2018": 1, "2019": 0, "2020": 2}}